The role of mesenchymal stem cells in hematopoietic stem cell transplantation: From bench to bedsides

Cell Transplantation

Volumn 22, Issue 4, 2013, Pages 723-729

  Wu, Kang Hsi ^a,b   Wu, Han Ping ^c   Chan, Chin Kan ^d,e   Hwang, Shiaw Min ^f   Peng, Ching Tien ^a,b,g   Chao, Yu Hua ^h,i  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e TAO YUAN GENERAL HOSPITAL   (Taiwan)

^f FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

^h CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

ⁱ CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cell based therapy; Graft versus host disease (GVHD); Hematopoietic stem cell transplantation (HSCT); Mesenchymal stem cells (MSCs)

Indexed keywords

BIOLOGICAL ACTIVITY; CANCER STEM CELL; ENGRAFTMENT; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR;

CLINICAL TRIALS AS TOPIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MESENCHYMAL STROMAL CELLS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84876485893     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X655217     Document Type: Review

References (62)

1. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822; 2005.
2. Almeida-Porada, G.; Flake, A. W.; Glimp, H. A.; Zanjani, E. D. Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp. Hematol. 27:1569-1575; 1999.
3. Almeida-Porada, G.; Porada, C. D.; Tran, N.; Zanjani, E. D. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 95:3620-3627; 2000.
4. Amariglio, N.; Hirshberg, A.; Scheithauer, B. W.; Cohen, Y.; Loewenthal, R.; Trakhtenbrot, L.; Paz, N.; Koren-Michowitz, M.; Waldman, D.; Leider-Trejo, L.; Toren, A.; Constantini, S.; Rechavi, G. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telan-giectasia patient. PLoS Med. 6:e1000029; 2009.
5. Antonucci, I.; Stuppia, L.; Kaneko, Y.; Yu, S.; Tajiri, N.; Bae, E. C.; Chheda, S. H.; Weinbren, N. L.; Borlongan, C. V. Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant. 20:789-795; 2011.
6. Bacigalupo, A.; Valle, M.; Podesta, M.; Pitto, A.; Zocchi, E.; De Flora, A.; Pozzi, S.; Luchetti, S.; Frassoni, F.; Van Lint, M. T.; Piaggio, G. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Exp. Hematol. 33:819-827; 2005.
7. Ball, L. M.; Bernardo, M. E.; Roelofs, H.; Lankester, A.; Cometa, A.; Egeler, R. M.; Locatelli, F.; Fibbe, W. E. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stemcell transplantation. Blood 110:2764-2767; 2007.
8. Banfi, A.; Muraglia, A.; Dozin, B.; Mastrogiacomo, M.; Cancedda, R.; Quarto, R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp. Hematol. 28:707-715; 2000.
9. Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 213:341-347; 2007.
10. Chan, C. K.; Wu, K. H.; Lee, Y. S.; Hwang, S. M.; Lee, M. S.; Liao, S. K.; Cheng, E. H.; See, L. C.; Tsai, C. N.; Kuo, M. L.; Huang, J. L. The comparison of interleukin-6 associated immunosuppressive effects of human ESCs, fetal-type MSCs, and adult-type MSCs. Transplantation 94:132-138; 2012.
11. Chang, J. W.; Hung, S. P.; Wu, H. H.; Wu, W. M.; Yang, A. H.; Tsai, H. L.; Yang, L. Y.; Lee, O. K. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant. 20:245-257; 2011.
12. Chao, Y. H.; Peng, C. T.; Harn, H. J.; Chan, C. K.; Wu, K. H. Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia. Ann. Hematol. 89:715-723; 2010.
13. Chao, Y. H.; Tsai, C.; Peng, C. T.; Wu, H. P.; Chan, C. K.; Weng, T.; Wu, K. H. Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia. Bone Marrow Transplant. 46:1391-1392; 2011.
14. Chapel, A.; Bertho, J. M.; Bensidhoum, M.; Fouillard, L.; Young, R. G.; Frick, J.; Demarquay, C.; Cuvelier, F.; Mathieu, E.; Trompier, F.; Dudoignon, N.; Germain, C.; Mazurier, C.; Aigueperse, J.; Borneman, J.; Gorin, N. C.; Gourmelon, P.; Thierry, D. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J. Gene Med. 5:1028-1038; 2003.
15. Corcione, A.; Benvenuto, F.; Ferretti, E.; Giunti, D.; Cappiello, V.; Cazzanti, F.; Risso, M.; Gualandi, F.; Mancardi, G. L.; Pistoia, V.; Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372; 2006.
16. da Silva, C. L.; Goncalves, R.; Crapnell, K. B.; Cabral, J. M. S.; Zanjani, E. D.; Almeida-Porada, G. A human stromal- based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp. Hematol. 33: 828-835; 2005.
17. Deans, R. J.; Moseley, A. B. Mesenchymal stem cells: Biology and potential clinical uses. Exp. Hematol. 28:875-884; 2000.
18. Deeg, H. J. How I treat refractory acute GVHD. Blood 109:4119-4126; 2007.
19. Ding, D. C.; Shyu, W. C.; Lin, S. Z. Mesenchymal stem cells. Cell Transplant. 20:5-14; 2011.
20. Di Nicola, M.; Carlo-Stella, C.; Magni, M.; Milanesi, M.; Longoni, P. D.; Matteucci, P.; Grisanti, S.; Gianni, A. M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843; 2002.
21. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006.
22. Friedenstein, A. J.; Piatetzky-Shapiro, I. I.; Petrakova, K. V. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16:381-390; 1966.
23. Friedman, R.; Betancur, M.; Boissel, L.; Tuncer, H.; Cetrulo, C.; Klingemann, H. Umbilical cord mesenchymal stem cells: Adjuvants for human cell transplantation. Biol. Blood Marrow Transplant. 13:1477-1486; 2007.
24. Glennie, S.; Soeiro, I.; Dyson, P. J.; Lam, E. W. F.; Dazzi, F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821-2827; 2005.
25. Gong, W.; Han, Z.; Zhao, H.; Wang, Y.; Wang, J.; Zhong, J.; Wang, B.; Wang, S.; Wang, Y.; Sun, L.; Han, Z. Banking human umbilical cord-derived mesenchymal stromal cells for clinical use. Cell Transplant. 21:207-216; 2012.
26. Hassan, Z.; Remberger, M.; Svenberg, P.; Elbander, M.; Omazic, B.; Mattsson, J.; Conrad, R.; Svahn, B. M.; Ahlgren, A.; Sairafi, D.; Aschan, J.; Le Blanc, K.; Barkholt, L.; Ringden, O. Hemorrhagic cystitis: A retrospective single-center survey. Clin. Transplant. 21:659-667; 2007.
27. Horowitz, M. M.; Gale, R. P.; Sondel, P. M.; Goldman, J. M.; Kersey, J.; Kolb, H. J.; Rimm, A. A.; Ringden, O.; Rozman, C.; Speck, B. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555-562; 1990.
28. Ito, Y.; Hasauda, H.; Kitajima, T.; Kiyono, T. Ex vivo expansion of human cord blood hematopoietic progenitor cells using glutaraldehyde-fixed human bone marrow stromal cells. J. Biosci. Bioeng. 102:467-469; 2006.
29. Jones, B. J.; McTaggart, S. J. Immunosuppression by mesenchymal stromal cells: From culture to clinic. Exp. Hematol. 36:733-741; 2008.
30. Kebriaei, P.; Isola, L.; Bahceci, E.; Holland, K.; Rowley, S.; McGuirk, J.; Devetten, M.; Jansen, J.; Herzig, R.; Schuster, M.; Monroy, R.; Uberti, J. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol. Blood Marrow Transplant. 15:804-811; 2009.
31. Keyser, K. A.; Beagles, K. E.; Kiem, H. P. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant. 16:555-562; 2007.
32. Koc, O. N.; Gerson, S. L.; Cooper, B. W.; Dyhouse, S. M., Haynesworth, S. E.; Caplan, A. I.; Lazarus, H. M. Rapid hematopoietic recovery after coinfusion of autologousblood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18:307-316; 2000.
33. Lazarus, H. M.; Koc, O. N.; Devine, S. M.; Curtin, P.; Maziarz, R. T.; Holland, H. K.; Shpall, E. J.; McCarthy, P.; Atkinson, K.; Cooper, B. W.; Gerson, S. L.; Laughlin, M. J.; Loberiza, Jr., F. R.; Moseley, A. B.; Bacigalupo, A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 11:389-398; 2005.
34. Lazennec, G.; Jorgensen, C. Concise review: Adult multipotent stromal cells and cancer: Risk or benefit? Stem Cells 26:1387-1394; 2008.
35. Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Dini, G.; Egeler, R. M.; Bacigalupo, A.; Fibbe, W.; Ringden, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586; 2008.
36. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Gotherstrom, C.; Hassan, M.; Uzunel, M.; Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441; 2004.
37. Le Blanc, K.; Samuelsson, H.; Gustafsson, B.; Remberger, M.; Sundberg, B.; Arvidson, J.; Ljungman, P.; Lonnies, H.; Nava, S.; Ringden, O. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21:1733-1738; 2007.
38. Li, N.; Feugier, P.; Serrurrier, B.; Latger-Cannard, V.; Lesesve, J. F.; Stoltz, J. F.; Eljaafari, A. Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity. Exp. Hematol. 35:507-515; 2007.
39. Lu, L. L.; Liu, Y. J.; Yang, S. G.; Zhao, Q. J.; Wang, X.; Gong, W.; Han, Z. B.; Xu, Z. S.; Lu, Y. X.; Liu, D.; Chen, Z. Z.; Han, Z. C. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis- supportive function and other potentials. Haematologica 91:1017-1026; 2006.
40. Lucchini, G.; Introna, M.; Dander, E.; Rovelli, A.; Balduzzi, A.; Bonanomi, S.; Salvade, A.; Capelli, C.; Belotti, D.; Gaipa, G.; Perseghin, P.; Vinci, P.; Lanino, E.; Chiusolo, P.; Orofino, M. G.; Marktel, S.; Golay, J.; Rambaldi, A.; Biondi, A.; D'Amico, G.; Biagi, E. Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population. Biol. Blood Marrow Transplant. 16:1293-1301; 2010.
41. Macmillan, M. L.; Blazar, B. R.; DeFor, T.; Wagner, J. E. Transplantation of ex vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial. Bone Marrow Transplant. 43:447-454; 2009.
42. Magatti, M.; De Munari, S.; Vertua, E.; Nassauto, C.; Albertini, A.; Wengler, G. S.; Parolini, O. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant. 18:899-914; 2009.
43. McIntosh, K.; Zvonic, S.; Garrett, S.; Mitchell, J. B.; Floyd, Z. E.; Hammill, L.; Kloster, A.; Di Halvorsen, Y.; Ting, J. P.; Storms, R. W.; Goh, B.; Kilroy, G.; Wu, X.; Gimble, J. M. The immunogenicity of human adipose-derived cells: Temporal changes in vitro. Stem Cells 24:1246-1253; 2006.
44. Minguell, J. J.; Erices, A.; Conget, P. Mesenchymal stem cells. Exp. Biol. Med. 226:507-520; 2001.
45. Nauta, A. J.; Westerhuis, G.; Kruisselbrink, A. B.; Lurvink, E. G. A.; Willemze, R.; Fibbe, W. E. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108:2114-2120; 2006.
46. Noort, W. A.; Kruisselbrink, A. B.; in't Anker, P. S.; Kruger, M.; van Bezooijen, R. L.; de Paus, R. A.; Heemskerk, M. H. M.; Lowik, C. W. G. M.; Falkenburg, J. H.; Willemze, R.; Fibbe, W. E. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp. Hematol. 30:870-878; 2002.
47. Pelagiadis, I.; Dimitriou, H.; Kalmanti, M. Biologic characteristics of mesenchymal stromal cells and their clinical applications in pediatric patients. J. Pediatr. Hematol. Oncol. 30:301-309; 2008.
48. Poloni, A.; Leoni, P.; Buscemi, L.; Balducci, F.; Pasquini, R.; Masia, M. C.; Viola, N.; Costantino, E.; Discepoli, G.; Corradini, P.; Tagliabracci, A.; Olivieri, A. Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. Leukemia 20:329-335; 2006.
49. Rasmusson, I.; Ringden, O.; Sundberg, B.; Le Blanc, K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76:1208-1213; 2003.
50. Ringden, O.; Leblanc, K. Pooled MSCs for treatment of severe hemorrhage. Bone Marrow Transplant. 46:1158-1160; 2011.
51. Ringden, O.; Uzunel, M.; Rasmusson, I.; Remberger, M.; Sundberg, B.; Lonnies, H.; Marschall, H. U.; Dlugosz, A.; Szakos, A.; Hassan, Z.; Omazic, B.; Aschan, J.; Barkholt, L.; Le Blanc, K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397; 2006.
52. Ringden, O.; Uzunel, M.; Sundberg, B.; Lonnies, L.; Nava, S.; Gustafsson, J.; Henningsohn, L.; Le Blanc, K. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 21:2271-2276; 2007.
53. Sattler, C.; Steinsdoerfer, M.; Offers, M.; Fischer, E.; Schierl, R.; Heseler, K.; Daubener, W.; Seissler, J. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation. Cell Transplant. 20:1221-1230; 2011.
54. Secco, M.; Zucconi, E.; Vieira, N. M.; Fogaca, L. L.; Cerqueira, A.; Carvalho, M. D.; Jazedje, T.; Okamoto, O. K.; Muotri, A. R.; Zatz, M. Multipotent stem cells from umbilical cord: Cord is richer than blood! Stem Cells 26:146-150; 2008.
55. Troyer, D. L.; Weiss, M. L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591-599; 2008.
56. Tsai, M. S.; Hwang, S. M.; Chen, K. D.; Lee, Y. S.; Hsu, L. W.; Chang, Y. J.; Wang, C. N.; Peng, H. H.; Chang, Y. L.; Chao, A. S.; Chang, S. D.; Lee, K. D.; Wang, T. H.; Wang, H. S.; Soong, Y. K. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 25:2511-2523; 2007.
57. von Bonin, M.; Stolzel, F.; Goedecke, A.; Richter, K.; Wuschek, N.; Holig, K.; Platzbecker, U.; Illmer, T.; Schaich, M.; Schetelig, J.; Kiani, A.; Ordemann, R.; Ehninger, G.; Schmitz, M.; Bornhauser, M. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysatecontaining medium. Bone Marrow Transplant. 43:245-251; 2009.
58. Weiden, P. L.; Sullivan, K. M.; Flournoy, N.; Storb, R.; Thomas, E. D. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneicmarrow transplantation. N. Engl. J. Med. 304:1529-1533; 1981.
59. Wu, K. H.; Chan, C. K.; Tsai, C.; Chang, Y. H.; Sieber, M.; Chiu, T. H.; Ho, M.; Peng, C. T.; Wu, H. P.; Huang, J. L. Effective treatment of severe steroid-resistant acute graftversus- host disease with umbilical cord-derived mesenchymal stem cells. Transplantation 91:1412-1416; 2011.
60. Yagi, H.; Soto-Gutierrez, A.; Parekkadan, B.; Kitagawa, Y.; Tompkins, R. G.; Kobayashi, N.; Yarmush, M. L. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 19:667-679; 2010.
61. Zhang, Z. Y.; Teoh, S. H.; Chong, M. S. K.; Schantz, J. T.; Fisk, N. M.; Choolani, M. A.; Chan, J. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 27:126-137; 2009.
62. Zhou, H.; Guo, M.; Bian, C.; Sun, Z.; Yang, Z.; Zeng, Y.; Ai, H.; Zhao, R. C. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: Clinical report. Biol. Blood Marrow Transplant. 16:403-412; 2010.